ACS Medicinal Chemistry Letters · 2014 · 41 citations · 11 references
Molecular BiologyAntiviral DrugMedicinal ChemistryAntiviral Drug DevelopmentNaphthyl Phenyl EthersResistance Mutation (Virology)BiochemistryHiv-1 Reverse TranscriptaseCatechol DiethersVirologyHivPharmacologyAntiviral CompoundPicomolar InhibitorsNatural SciencesKey Compound 6ERational Drug DesignAntiviral TherapyMedicineDrug Discovery
Catechol diethers that incorporate a 6-cyano-1-naphthyl substituent have been explored as non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs). Promising compounds are reported that show midpicomolar activity against the wild-type virus and sub-20 nM activity against viral variants bearing Tyr181Cys and Lys103Asn mutations in HIV-RT. An X-ray crystal structure at 2.49 Å resolution is also reported for the key compound 6e with HIV-RT.
11
Ilse Weuts, Frederic Van Dycke, Jody Voorspoels et al. · Journal of Pharmaceutical Sciences · 2010 · 116 citations
Tai‐Shun Lin, Luo Mei-Zhen, Mao‐Chin Liu et al. · Biochemical Pharmacology · 1994 · 93 citations